A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes (Q47916425)
Jump to navigation
Jump to search
scientific article published on 4 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes |
scientific article published on 4 March 2013 |
Statements
1 reference
A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes (English)
1 reference
E Ferrannini
1 reference
L Seman
1 reference
E Seewaldt-Becker
1 reference
S Hantel
1 reference
S Pinnetti
1 reference
H J Woerle
1 reference
4 March 2013
1 reference
15
1 reference
8
1 reference
721-728
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference